Patients can sleep during deep brain stimulation procedure using
IRVINE, CA, and MINNEAPOLIS, MN, Dec. 3, 2013 /CNW/ - IMRIS Inc.
(NASDAQ: IMRS; TSX: IM) ("IMRIS") and MRI Interventions, Inc. (OTCQB:
MRIC) today announced that Cook Children's Medical Center in Fort
Worth, Texas, is the first U.S. pediatric hospital to offer asleep deep
brain stimulation (DBS) surgery to children suffering from dystonia by
utilizing the combination of MRI Interventions' ClearPoint® Neuro Intervention System and an IMRIS VISIUS® Surgical Theatre for real-time intraoperative image guidance and
"The VISIUS iMRI and ClearPoint guidance platform make DBS surgery an
option for these children," said Dr. John Honeycutt, Medical Director
of the Cook Children's Department of Neurosurgery, who led the first
two pediatric asleep DBS procedures in early November. "It is very
difficult for children to remain awake during surgery, and the
real-time intraoperative visualization and guidance we use with these
technologies means they do not have to."
DBS surgery is usually performed on patients who are awake so the
surgeon can assess the placement of leads (wires) by observing the
effect of stimulation in an area of the brain. This is very difficult
for children to manage, and children with dystonia have a lot of
involuntary movement. However, the combination of ClearPoint and
VISIUS iMRI technologies enables Dr. Honeycutt to observe the surgical
instruments and exact target location in the patient's brain throughout
the operation in real time, allowing these young patients to sleep
through surgery and reduce the anxiety associated with it.
Using these technologies, Dr. Honeycutt is able to see and select the
desired neurological target area, establish a trajectory, and visualize
the target on MR images as the electrode is inserted to the desired
Dystonia is a debilitating neurological movement disorder that causes
involuntary muscle contractions and twisting and repetitive movements.
DBS is an important therapeutic option for patients for whom medication
is not adequate treatment. The therapy involves the implantation of a
brain "pacemaker" device system, usually below the shoulder which sends
electrical impulses through wires to specific parts of the brain. The
electrical impulses are intended to interfere with the neural activity
that causes the involuntary movement and painful muscle contractions.
Unfortunately, children with dystonia often do not make good candidates
for conventional DBS surgery due to the awake nature of the lead
For neurosurgery, VISIUS iMRI at Cook Children's uniquely brings
high-field MRI to the patient inside the operating room on
ceiling-mounted rails. The fully integrated suite allows the scanner to
move between an operating room and a diagnostic room, providing
on-demand access to high resolution MR images - before, during and
after procedures without moving the patient.
The ClearPoint platform is the only technology that enables
minimally-invasive neurosurgery under continuous MRI guidance, which
provides superior visualization of the brain's tissue compared to other
imaging technologies and is the only imaging technology that will
safely allow continuous soft tissue visualization during surgery.
In addition to asleep DBS, the ClearPoint system has been used within a
VISIUS Surgical Theatre to facilitate focal laser ablation and direct
drug delivery in the brain.
"As one of a select group of pediatric neurosurgical centers with an
IMRIS iMRI today and one of the largest neurosurgical programs in the
Southwest, we continue to demonstrate our institution's commitment to
the care of children with these complex neurological disorders,"
Honeycutt added. "Our adoption of the ClearPoint system in the VISIUS
iMRI to enable asleep DBS for these young patients is representative of
About IMRIS, Inc.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 54 leading medical
institutions around the world.
About MRI Interventions, Inc.
Founded in 1998, MRI Interventions is creating innovative platforms for
performing the next generation of minimally invasive surgical
procedures in the brain and heart. Utilizing a hospital's existing MRI
suite, the company's FDA-cleared and CE-marked ClearPoint® System is designed to enable a range of minimally invasive procedures
in the brain. In partnership with Siemens Healthcare, MRI
Interventions is developing the ClearTrace® System to enable MRI-guided catheter ablations to treat cardiac
arrhythmias, including atrial fibrillation. Building on the imaging
power of MRI, the company's interventional platforms strive to improve
patient care while reducing procedure costs and times. MRI
Interventions is also working with Boston Scientific Corporation to
incorporate its MRI-safety technologies into Boston Scientific's
implantable leads for cardiac and neurological applications. For more
information, please visit www.mriinterventions.com.
Certain matters in this press release may constitute forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements by their nature address matters that, to
different degrees, are uncertain and involve risk. Uncertainties and
risks may cause MRI Interventions' actual results and the timing of
events to differ materially from those expressed in or implied by MRI
Interventions' forward-looking statements. Particular uncertainties and
risks include, among others: demand and market acceptance of our
products; our ability to successfully expand our sales and clinical
support capabilities; availability of third party reimbursement; the
sufficiency of our cash resources to maintain planned commercialization
efforts and research and development programs; future actions of the
FDA or any other regulatory body that could impact product development,
manufacturing or sale; our ability to protect and enforce our
intellectual property rights; our dependence on collaboration partners;
the impact of competitive products and pricing; and the impact of the
commercial and credit environment on us and our customers and
suppliers. More detailed information on these and additional factors
that could affect MRI Interventions' actual results are described in
MRI Interventions' filings with the Securities and Exchange Commission,
including, without limitation, MRI Interventions' Quarterly Report on
Form 10-Q filed with the Securities and Exchange Commission on November
13, 2013. Except as required by law, MRI Interventions undertakes no
obligation to publicly update or revise any forward-looking statements
contained in this press release to reflect any change in MRI
Interventions' expectations or any change in events, conditions or
circumstances on which any such statements are based.
Image with caption: "Cook Children's Medical Center in Fort Worth, Texas, is the first U.S. pediatric hospital to offer asleep deep brain stimulation (DBS) surgery to children suffering from dystonia by utilizing technologies from MRI Interventions IMRIS for real-time intraoperative image guidance and procedure visualization. (CNW Group/IMRIS Inc.)". Image available at: http://photos.newswire.ca/images/download/20131203_C7170_PHOTO_EN_34257.jpg
SOURCE: IMRIS Inc.
For further information:
For further MRI Interventions, Inc. Contact Information:
MRI Interventions, Inc.
David Carlson, CFO, 901-522-9300
For further IMRIS, Inc. information, please contact:
Kevin J. Berger
Marketing Communications Manager